Viewing StudyNCT00088660



Ignite Creation Date: 2024-05-05 @ 11:35 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00088660
Status: UNKNOWN
Last Update Posted: 2006-02-08
First Post: 2004-07-30

Brief Title: PANVAC-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen
Sponsor: Therion Biologics Corporation
Organization: Therion Biologics Corporation

Organization Data

Organization: Therion Biologics Corporation
Class: INDUSTRY
Study ID: TBC-PAN-003
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Therion Biologics Corporation
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators